Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05083754
Title Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Indications

gliosarcoma

glioblastoma

Therapies

Retifanlimab

Temozolomide

Retifanlimab + Temozolomide

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.